🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
PREMIERE parallel, non-comparative, two-arm, randomized 1:1, open-label, mu...
Status
Recruiting
Location
ICO Badalona
Start Date
2023-02-03
Trial ID
NCT05982093
Treatments Being Tested
This study is to evaluate the efficacy and safety of elacestrant, in partic...
Status
Recruiting
Location
Dana Farber Cancer Institute
Start Date
2026-03-25
Trial ID
NCT07467772
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and preli...
Status
Completed
Location
Radius Pharmaceuticals, Inc.
Start Date
2015-01
Trial ID
NCT02338349
Treatments Being Tested
This is an international, multisite, open-label, Phase 1b/2 study, to confi...
Status
Completed
Location
Site 38 - Northwestern University, Feinberg School of Medicine, Northwestern University
Start Date
2023-10-09
Trial ID
NCT05963997
Treatments Being Tested
This Phase 3 clinical study compares the efficacy and safety of elacestrant...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2019-05-10
Trial ID
NCT03778931
Treatments Being Tested
The primary goal of this study is to evaluate the effectiveness of elacestr...
Status
Recruiting
Location
Southern Cancer Center, PC
Start Date
2024-09-27
Trial ID
NCT06492616
Treatments Being Tested
Single agent endocrine therapy (ET), with selective estrogen receptor degra...
Status
Recruiting
Location
European Institute of Oncology
Start Date
2026-05-11
Trial ID
NCT07395336
Treatments Being Tested
This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KA...
Status
Recruiting
Location
Highlands Oncology Group
Start Date
2024-10-25
Trial ID
NCT06638307
Treatments Being Tested
The purpose of this study is to visualize and quantify ER-binding sites dur...
Status
Completed
Location
Institut Jules Bordet
Start Date
2016-04-01
Trial ID
NCT02650817
Treatments Being Tested
A prospective randomized trial designed to evaluate the mean decrease in Ki...
Status
Recruiting
Location
Gustave Roussy
Start Date
2025-10-06
Trial ID
NCT07159451
Treatments Being Tested